A reprogrammable transgenic mouse strain, called Col1a1 4F2A-Oct4-GFP, was bred for the present study. Because the somatic cells of this mouse strain contain only two copies of each Yamanaka factor, these animals are inefficient at producing induced pluripotent stem cells (iPSCs; approx. 0.005%) under traditional culture conditions. With an optimized culture condition, the iPSC production rate of mouse embryonic fibroblasts (MEFs) of Col1a1 4F2A-Oct4-GFP mice (MEF Col1a1 4F2A-Oct4-GFP ) was increased to approximately 8%. Further, promotion of cell proliferation by serum supplementation did not enhance iPSC production. Inhibition of transforming growth factor b (TGF-b) in the serum by SB431542 neither affected the growth rate of MEFCol1a1 4F2A-Oct4-GFP nor promoted iPSC production. However, the use of the gamma-irradiated STO-NEO-LIF (cSNL) cells to serve as feeders for iPSC production resulted in a 5-fold higher rate of iPSC production than the use of cMEF ICR feeders. Interestingly, the use of SB431542 with the cMEF ICR -adopted system could eliminate this difference. RT-PCR-based comparative analysis further demonstrated that TGF-b expression was 10-fold higher in cMEF ICR than in cSNL cells. Consistent with previous reports, mesenchymal to epithelial transition was found to participate in the initial steps of reprogramming in the specific context of MEF Col1a1 4F2A-Oct4-GFP . Moreover, we found that the initial seeding density is one of the pivotal factors for determining a high efficiency of iPSC generation. The iPSCs efficiently generated from our MEF Col1a1 4F2A-Oct4-GFP resembled mouse embryonic stem cells (mESCs) in aspects of teratoma formation and germline transmission. Depending on the culture conditions, our Col1a1 4F2A-Oct4-GFP mouse system can generate bona fide iPSCs with variable efficiencies, which can serve as a tool for interrogating the route taken by cells during somatic reprogramming.
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Introduction
Highly differentiated somatic cells are able to regain pluripotency by overexpressing Yamanaka factors (Oct4, Sox2, Klf4 and c-Myc; OSKM) to reconstruct their epigenetic landscape through the process of chromatin remodeling. Our previous studies along with those of others demonstrated that effective strategies to deliver these exogenous factors include virus-and transposon-mediated approaches [1] [2] [3] . Although such strategies result in robust induced pluripotent stem cell (iPSC) production, a major limitation is that not every cell acquires the full complement of reprogramming factors. In addition, there exists heterogeneity in the expression of each Yamanaka factor because of the unique pattern of transgene incorporation in each cell [4, 5] . Hence, the study of the molecular mechanisms of pluripotency reacquisition is mostly hampered by the current vector-mediated strategy of iPSC production.
A secondary mouse embryonic fibroblast (MEF) model was proposed to avoid the issue of heterogeneity. However, uncertainty in the transgene insertion sites may introduce further complexity due to interference with the function of neighboring genes, resulting in a failure to reveal the route taken during somatic reprogramming [6] . To overcome these difficulties, a triple-transgenic mouse, the Col1a1 4F2A-Oct4-GFP mouse, was bred for this study in which an OSKM knock-in cassette was used in combination with a doxycycline-inducible reverse tetracycline transactivator (rtTA) and Oct4-gfp transgenes. In the homozygous Col1a1 4F2A-Oct4-GFP mouse, there are two copies of the OSKM cassette located in the 3 0 -untranslated region of the collagen locus (Col1a1) under the control of a doxycycline-inducible rtTA, which avoids the positional effect observed in vector-mediated approaches. Thus, each somatic cell is capable of responding to doxycycline induction to undergo somatic reprogramming. However, due to the presence of two copies of the OSKM cassette, the somatic reprogramming of MEFs of Col1a1 4F2A-Oct4-GFP mice (MEF Col1a1 4F2A-Oct4-GFP ) is inefficient under traditional culture conditions. In this study, we optimized this iPSC generation system by adopting various culture systems and observed different iPSC production rates in each tested system. Among the tested media, we found that the iCD medium can efficiently promote iPSC generation from MEF Col1a1 4F2A-Oct4-GFP . In addition, we found that the iPSC production from MEF Col1a1 4F2A-Oct4-GFP was greatly affected by the choice of feeder layer and initial seeding density of MEF Col1a1 4F2A-Oct4-GFP . Although the kinetics of somatic reprogramming cannot be distinguished from those in the media mentioned above, we were able to observe the different effects based on morphological changes during the progression of somatic reprogramming. Taken together, the reprogrammable Col1a1 4F2A-Oct4-GFP mouse strain provides an ideal platform for studying the choice of route taken by cells during somatic reprogramming under different conditions as well as in different cell types. Uncovering the optimized reprogramming route in different cell types will help generate efficient and safe iPSCs for clinical applications.
Results

Establishment of the Col1a1 4F2A-Oct4-GFP mouse
To generate the Col1a1 4F2A-Oct4-GFP triple-transgenic mouse strain, the Col1a1 4F2A mouse (011004; The Jackson Laboratory, Bar Harbor, ME, USA) was mated with the homozygous rtTA and Oct4-gfp double-transgenic mouse (generated in our lab by crossing 008214 with 006965; The Jackson Laboratory). Although both 011004 and 006965 strains harbor the same rtTA-M2 coding sequence inserted in the Rosa26 locus, they have different genetic backgrounds. A PCR-based method was adopted to verify the genotype. The triple-transgenic mouse, hereafter referred to as Col1a1 4F2A-Oct4-GFP, is viable but with a smaller litter size compared with C57B6, which is the background strain of the Col1a1 4F2A-Oct4-GFP mouse.
MEF
Col1a1 4F2A-Oct4-GFP respond to doxycycline induction and alteration of cell fate Since the Yamanaka factor-encoding gene cassette (the OSKM cassette) in the Col1a1 4F2A-Oct4-GFP transgenic strain was controlled by a doxycycline-mediated regulatory system where the Col1a1 locus was knocked in, we first tested the expression of the OSKM cassette in the presence and absence of doxycycline. To this end, MEFs of Col1a1 4F2A-Oct4-GFP mice (hereafter referred to as MEF Col1a1 4F2A-Oct4-GFP ) were extracted from E13.5 embryos and cultured in MEF medium in the presence of doxycycline (1.5 lgÁmL
À1
). As shown in Fig. 1A , the expression level of the OSKM cassette increased and reached a plateau at 72 h post-doxycycline induction. To quantify the percentage of doxycycline responsive cell, the MEF Col1a1 4F2A-Oct4-GFP cultured in different media was subject to 1.5 lgÁmL À1 doxycycline treatment, and immunostaining with OCT4 antibody was performed to observe the exogenous Oct4 expression. As shown in Fig. 2A , the exogenous Oct4 expression reached almost 100% under doxycycline treatment in different culture media whereas the untreated controls showed no transgene expression. Figure 2B displays a representative cell for exogenous Oct4 expression in the presence of doxycycline.
To observe whether the expression of the OSKM cassette drove cell fate alterations in MEF Col1a1 4F2A-Oct4-GFP , a set of fibroblast marker genes was examined including Snail1, Snail2, Thy1 and Tgfb3. During a 72 h course of doxycycline induction, all of the tested fibroblast biomarkers were significantly decreased at the first 24 h post-doxycycline induction and remained at this low level for the next 48 and 72 h compared to the corresponding pre-doxycycline levels (Fig. 1B) . The decrease in the fibroblast markers accompanying the up-regulation of Yamanaka factors indicated a change in the cell fate of MEF Col1a1 4F2A-Oct4-GFP .
MEF
Col1a1 4F2A-Oct4-GFP are able to generate iPSCs in chemically defined medium
The conventional method to generate murine iPSCs from MEFs involves a~2-3-week period of Each data point was normalized to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and represented as an average of triplicate assays with standard deviation. *P < 0.05; **P < 0.005.
de-differentiation and results in a~0.01-0.5% efficiency of iPSC production [1, 4, [7] [8] [9] . In addition to the introduction of the Yamanaka factors, the traditional culture system also needs the presence of serum to support the maturation of iPSCs. Since the undefined culture conditions represent a hurdle to experimental insights and drug screening, we adopted various media including chemically defined media to test the efficiency of formation of iPSCs from MEF Col1a1 4F2A-Oct4-GFP [4, 10, 11] . After verifying that the doxycycline-based regulatory element was able to tightly control the expression of the OSKM cassette and alter the expression of fibroblast biomarkers, we performed somatic reprogramming using MEF Col1a1 4F2A-Oct4-GFP as a starting somatic cell source. In 2010, Chen et al. [12] developed the iSF medium, a chemically defined medium that is able to support iPSC generation from MEFs without the need for changing the components of the medium during the course of somatic reprogramming. We, therefore, adopted this recipe for testing the efficiency of iPSC generation from MEF Col1a1 4F2A-Oct4-GFP . Accordingly, 1 9 10 5 MEF Col1a1 4F2A-Oct4-GFP were seeded on a feeder layer containing gamma-irradiated E13.5 MEF ICR (hereafter referred to as cMEF ICR ) in each well of a six-well plate. The day when the
Col1a1 4F2A-Oct4-GFP were first seeded in the iSF medium containing 1.5 lgÁmL À1 doxycycline was designed as day 0 (Fig. 3A) . As shown in Fig. 3C , the iPSC generation efficiency was quite low (approx. 0.002-0.005%; i.e.~2-5 out of 1 9 10 5 cells), whereas the MEF and mouse embryonic stem cell (mESC) media were unable to generate iPSCs from MEF Col1a1 4F2A-Oct4-GFP altogether. Unlike conventional virus-and transposon-mediated methods that introduce multiple copies of exogenous factors, MEF Col1a1 4F2A-Oct4-GFP contains only two copies of the genes encoding the Yamanaka factors per genome. Conceivably, this might result in a reduction in iPSC generation efficiency. Although a relatively low efficiency was observed in the iSF medium, all of the iSF-derived iPSC clones had a typical dome-shaped compact morphology with a distinct border and could be expanded in the absence of doxycycline, which is a strong indicator of successful reprogramming (Fig. 3B ) [4, 13] .
Different culture media affect the proliferation of MEF Col1a1 4F2A-Oct4-GFP in vitro
Using the iSF medium to generate iPSCs from MEF Col1a1 4F2A-Oct4-GFP , it was uncommon to see the aggregation of cell clones during the entire course of somatic reprogramming, resulting in low iPSC generation efficiency. Because cell proliferation is required for the re-establishment of epigenetic markers of differentiated cells during the initial stages of somatic reprogramming [14, 15] , we adopted different culture systems to identify a medium that will promote the proliferation of MEF Col1a1 4F2A-Oct4-GFP . Previously, several culture systems have been reported and demonstrated to support iPSC generation with or without feeder cells [12, 16, 17] . Here, we systematically compared several different media for their effect on the proliferation rate of MEF Col1a1 4F2A-Oct4-GFP during initial iPSC generation.
On day 0, 5 9 10 4 MEF Col1a1 4F2A-Oct4-GFP were cultured in MEF medium and seeded in each well of a six-well plate coated with 0.1% gelatin. The next day, different media were used in the wells, namely MEF, iSF, iSF + VC6TFN, iCD, iCD + VC6TFN, iCD + 10% FBS and VC6TFN [12, 16, 17] . The number of cells was counted on days 2, 4 and 6 to quantify cell proliferation (n = 3). As shown in Fig. 4A , iCD + 10% FBS and VC6TFN media displayed a 2-and 1.5-fold increase in cell number on day 6, respectively, compared with the MEF medium. The other media had only a marginal effect on cell proliferation. Cells grown in all the tested media reached a growth plateau on day 2 except those grown in iCD + 10% FBS. When 1.5 lgÁmL À1 doxycycline was added to each of the growth systems, the growth curves displayed an exponential pattern in response to iSF + VC6TFN, VC6TFN and iCD + 10% FBS and reached a plateau, whereas the growth curves for the other media displayed a similar pattern as seen in the absence of doxycycline (Fig. 4B) . Thus, the effect of Yamanaka factors in triggering cell proliferation depends on the growth medium.
High efficiency of iPSC generation does not depend on the ability of the culture medium to support the initial rapid proliferation of MEF
The use of different media resulted in variations in the proliferation of MEF Col1a1 4F2A-Oct4-GFP . Next, we used the tested media to generate iPSCs and observe whether the iPSC generation rate is correlated with the proliferative capability of MEF Col1a1 4F2A-Oct4-GFP . To this end, 1 9 10 5 MEF Col1a1 4F2A-Oct4-GFP were seeded on cMEF ICR feeders in the corresponding media in the presence of doxycycline. As shown in Fig. 4C , dramatic differences were observed among the different media, and only the iCD medium was able to give efficient iPSC generation. Within a 2-week induction period, the iPSC generation efficiency reached 0.05%. One week later, it reached 0.09%, whereas it only reached 0.005% in the iSF medium. The rest of the tested media, including the iCD + 10% FBS and VC6TFN media, resulted in the generation of fewer than five iPSC clones. Although different genetic backgrounds may affect iPSC generation, this process requires proliferation of MEFs at the initial stages of reprogramming [14, 15] . However, the promotion of MEF Col1a1 4F2A-Oct4-GFP proliferation by different media at initial stages of somatic reprogramming does not always result in iPSC production, indicating that mechanisms other than cell proliferation participate in initial reprogramming events. Alternatively, the specific components in each medium may bias the stochastic events at the onset of reprogramming, which could be equivalent to the effect of cell proliferation.
Distinct processes of iPSC generation observed under different culture conditions
It is interesting to note that distinct processes of iPSC generation were observed with each adopted medium.
In the iSF medium, few MEF Col1a1 4F2A-Oct4-GFP were observed to produce the Oct4-GFP signal on the second day of doxycycline induction. However, the GFPpositive cells still maintained fibroblast morphology until approximately days 3-5 post-doxycycline induction. Most of the bright Oct4-GFP-positive cells were unable to de-differentiate to iPSCs. Only a small fraction of that population reached the final iPSC stage with a discernable stem cell-like morphology as well as homogeneous GFP expression. In the iSF + VC6TFN medium, the kinetics of alteration of cellular morphology was similar to those with the iSF medium alone. One major difference was that the affected cells did not express Oct4-GFP. On approximately the seventh to ninth days of post-doxycycline induction, the cells aggregated to form dome-shaped colonies, which represents a stem cell-like clonal morphology, but they did not express Oct4-GFP. Five to eight of those cell aggregations were observed in every 10 5 MEF Col1a1 4F2A-Oct4-GFP seeded in the first 2 days of induction. However, they were found to collapse and dissipate immediately in the following few days.
In the iCD medium, MEF Col1a1 4F2A-Oct4-GFP began to change their morphology on approximately days 3-5 post-doxycycline induction. The onset of Oct4-GFP expression was observed on the seventh day post-doxycycline. At this stage, the putative iPSC clones had already formed compact dome-shaped stem cell-like colonies and begun to express Oct4-GFP homogeneously (Fig. 4D) . It is interesting to note that the entire process of somatic reprogramming was different if 10% FBS was added to the iCD medium. Although the iCD + 10% FBS medium sustained the rapid proliferation of MEF Col1a1 4F2A-Oct4-GFP (Fig. 4A,B) , it was neither able to drive the expression of Oct4-GFP nor result in stem cell-like aggregation. Further, if VC6TFN was added to the iCD medium, cell death was aggravated in the first 7 days of doxycycline induction. There was no Oct4-GFP expression observed during the entire course of induction.
We also used a combination of six small-molecule compounds (VC6TFN) with 10% FBS to generate iPSCs [17] . The proliferation rate of MEF Col1a1 4F2A-Oct4-GFP with this medium was the same as that seen in the iCD + 10% FBS in the first 2 days. Then, the proliferation rate reached a plateau on the fourth and sixth days, respectively (Fig. 4A ). In the VC6TFN culture medium, the treated MEF Col1a1 4F2A-Oct4-GFP formed large aggregates but without a clear clonal boundary. The cell aggregates expressed low levels of Oct4-GFP on approximately days 7-9 post-doxycycline induction, and the colonies dissipated within 2 days (on approximately days 9-11).
It has been suggested that many routes can be taken by cells during somatic reprogramming to regain pluripotency. The choice of route depends on the use of different factor combinations as well as on the degree and order of expression of each transgene [18] . In the present study, we observed that different media may also result in different route decisions. Some of the media might not provide an efficient route to enable MEF Col1a1 4F2A-Oct4-GFP to acquire pluripotency, although the media were still sufficient to alter the fibroblast cell fate.
Initial MEF seeding density and feeder adoption affect iPSC generation
Although both iCD + 10% FBS and VC6TFN media sustained the rapid proliferation of MEF Col1a1 4F2A-Oct4-GFP , they failed to generate iPSCs efficiently (Fig. 4C) . We suspected that the high proliferation rates in our culture systems might cause overcrowding of cells and in turn induce contact inhibition, thereby impeding the subsequent steps of somatic reprogramming. To test this possibility, a 10 times fewer MEF Col1a1 4F2A-Oct4-GFP (i.e. 1 9 10 4 cells) was seeded on cMEF ICR feeders, with the respective doxycycline-containing media to generate iPSCs. Interestingly, both 1 9 10 5 and 1 9 10 4 MEF Col1a1 4F2A-Oct4-GFP resulted in a comparable efficiency for iPSC generation (Fig. 5A ).
Additionally, we tested whether different feeder layers affect the efficiency of iPSC generation in MEF Col1a1 4F2A-Oct4-GFP . Previously, we had used cMEF ICR as feeders. Here, we adopted different feeder systems, namely the gamma-irradiated STO-NEO-LIF (cSNL) cells and cMEF DR4 , to test their iPSC-supporting capability [19, 20] . As shown in Fig. 5B , seeding 1 9 10 5 MEF Col1a1 4F2A-Oct4-GFP on the indicated feeders resulted in distinct iPSC-supporting capabilities. For example, the cSNL cells enhanced the efficiency of iPSC generation by approximately 9-fold in iCD medium (0.8%; i.e.~800 out of 1 9 10 5
MEF
Col1a1 4F2A-Oct4-GFP ) compared with the cMEF ICR as feeders, whereas the effect of cMEF DR4 was indistinguishable from that of cMEF ICR feeders.
Since the use of cSNL cells as feeders can efficiently generate iPSCs, we asked whether seeding 10 times fewer MEF Col1a1 4F2A-Oct4-GFP (i.e. 1 9 10 4 ) can result in iPSC generation. Consistent with our previous results, a comparable number of iPSC clones were generated with both 1 9 10 4 and 1 9 10 5 cells (Fig. 4A) . Although our system can sustain 1 9 10 5
Col1a1 4F2A-Oct4-GFP to produce iPSCs, a 10 times lower number of cells (1 9 10 4 MEF Col1a1 4F2A-Oct4-GFP ) is sufficient to generate a comparable number of iPSC clones. It is worth noting that the MEF Col1a1 4F2A-Oct4-GFP proliferation pattern in different tested media is invariant with regard to seeding density in our applied system (i.e. 1 9 10 4 vs 1 9 10 5 cells; data not shown). Altogether, the iPSC generation rate reached 8% (approximately 800 out of 1 9 10 4 MEF Col1a1 4F2A-Oct4-GFP ) with the iCD medium along with the cSNL feeder cells.
With an adequate seeding number of MEF Col1a1 4F2A-Oct4-GFP and a proper feeder layer, the MEF Col1a1 4F2A-Oct4-GFP system resulted in very efficient iPSC generation in a chemically defined medium with only two copies of each Yamanaka factor. However, our system could only generate a few iPSCs in gelatin-or Matrigel-coated plates (Fig. 5C) . Thus, the potential cell-cell contact and paracrine secretion from feeder cells may be indispensable elements during the process of somatic reprogramming.
TGF-b secreted from feeder cells impedes iPSC generation
With the epigenetic barrier set during the development of fibroblasts, mesenchymal-epithelial transition (MET) is likely the earliest event that the somatic units). The soft agarose assay was conducted on the M1 cell. As the result here shows, the LIF in the iCD medium is more potent in promoting M1 cell proliferation than the cSNL conditioned medium counterpart. Error bars represent the standard deviation; n = 3.
reprogramming needs to execute. Thus, we wondered whether lowering the MET barrier may promote iPSC generation in MEF Col1a1 4F2A-Oct4-GFP . TGF-b has been recognized as a MET blocker [21, 22] and an epithelial-mesenchymal transition inducer [23] that is abundant in the serum. We, therefore, tested whether MET was the rate-limiting step of the initial steps of iPSC generation in MEF Col1a1 4F2A-Oct4-GFP . As SB431542, a TGF-b blocker, targets type I TGF-b receptors, such as Alk-4, Alk-5 and Alk-7, it has been used to suppress the epithelial-mesenchymal transition-promoting function of TGF-b. To this end, we tested whether SB431542 affects the proliferation of MEF Col1a1 4F2A-Oct4-GFP and subsequently the efficiency of somatic reprogramming.
As shown in Fig. 6A , the presence of SB431542 in all the test media, including iCD, iCD + 10% FBS and MEF, did not affect MEF Col1a1 4F2A-Oct4-GFP proliferation, but it did improve the efficiency of iPSC generation when the MEFs were seeded on cMEF ICR feeder cells (Fig. 6B) . The efficiency of iPSC generation in the iCD/SB431542/cMEF ICRmediated system reached 8%, which is comparable to the proportion seen when the cells were seeded on cSNL feeder cells (Fig. 5B) . Therefore, the lower efficiency of iPSC generation in cMEF ICR may have resulted from the differential expression of TGF-b between cMEF ICR and cSNL. To test this hypothesis, the quantification of TGF-b expression in the feeder cells was performed using RT-PCR. As shown in Fig. 6C , the expression of TGF-b was significantly higher in cMEF ICR than that in cSNL cells. Consistently, the secreted TGF-b in the culture medium was also higher in cMEF ICR over the 24 h time course (Fig. 6D) . Further, reduced efficiency of iPSC generation was observed in both cSNL-and cME-F ICR -adopted systems when TGF-b was present (Fig. 6E) . In Fig. 6E we used conditioned medium from cSNL to induce the generation of iPSCs when MEF Col1a1 4F2A-Oct4-GFP were cultured on cMEF ICR feeder. Under these culture conditions, the iPSC generation rate was improved 3-fold at the 21st day (53 clones generated from cSNL conditioned medium vs 17 clones produced from cMEF ICR conditioned medium). In the presence of TGF-b, both cSNL and cMEF ICR conditioned media could not efficiently support the process of somatic reprogramming; the presence of TGF-b in the cSNL conditioned medium resulted in 17-fold reduction in iPSC clone production at the 21st day (53 vs 3 clones) whereas the cMEF ICR conditioned medium with TGF-b failed to support iPSC formation. Next, we used SB431542 to inhibit the effect of TGF-b derived from cMEF ICR feeder during somatic reprogramming. The SB431542 supplementation was removed on day 3, 7, 14 and 21 during the course of iPSC generation. As shown in Fig. 6F , an improvement of iPSC generation was observed in the groups where SB431542 was added to the medium for more than 7 days. In the presence of SB431542 for more than 14 and 21 days, the iPSC efficiency was comparable to seeding on cSNL.
Although differential amounts of TGF-b were observed in cSNL and cMEF ICR , and SB431542 was able to eliminate such a differential reprogramming effect, one cannot ignore the fact that SNL was engineered to express leukemia inhibitory factor (LIF) (but not the MEF ICR ), which may account for the enhancement of iPSC formation when it served as the feeder. The secreted LIF from cSNL may trigger the activation of signal transducer and activator of transcription 3 (STAT3) and in turn promote the pluripotent cell fate [19] . To rule out this possibility, we measured the amount of LIF and its functionality in the medium using ELISA and soft agar assay, respectively. As seen in Fig. 6G ,H, our applied iCD medium contained a much higher amount of functional LIF than that of the cSNL secretion. Therefore, the different ability to support iPSC generation of cSNL and cMEF ICR is unlikely due to the differential amount of LIF expression in those feeder cells.
Consistent with previous reports, MET is also the major obstacle in MEF Col1a1 4F2A-Oct4-GFP -based somatic reprogramming. In addition, a 10-fold higher level of TGF-b expression in cMEF ICR , at least in part, made cMEF ICR inferior as an iPSC-supporting feeder compared to cSNL feeder cells. In our MEF Col1a1 4F2A-Oct4-GFP system, MET was observed around day 7 post-doxycycline induction, which is consistent with the onset of the Oct4-GFP expression.
iPSC
Col1a1 4F2A-Oct4-GFP displays pluripotency markers, forms teratoma in NOD-SCID mice and possesses germline transmission capacity
To verify whether the iPSCs derived from MEF Col1a1 4F2A-Oct4-GFP really acquired pluripotency, we first performed immunostaining to detect the expression of core pluripotency-associated network genes. As seen in Fig. 7A , the iPSC clones stained positively for alkaline phosphatase (AP), SSEA1, Sox2, Oct4 and Nanog. Consistent with the immunostaining of pluripotency markers, quantitative RT-PCR assessment of pluripotent genes, including Oct4, Sox2, Klf4, Nanog, Rex1, PECAM, Zscan4 and Esrrb, displayed a comparable expression level to that seen with JM8A3 and R1 ESCs as controls (Fig. 7B) . It is worth noting that although the primer pair for detecting Oct4 expression cannot distinguish Oct4A and Oct4B, the Oct4 antibody used in the Fig. 7A specifically targets OCT4A protein which is the pluripotency marker.
To further examine the fluctuation in gene expression accompanying cell fate changes during the course of somatic reprogramming, a time course of gene expression was determined. Previously, three main stages of somatic reprogramming had been reported, namely initiation, maturation and stabilization, and the genes that correspond to each stage had also been defined [24] . Before inducing the expression of the Yamanaka factors, the MEF Col1a1 4F2A-Oct4-GFP expressed high levels of Snail1 and Snail2, two fibroblast markers. During the progression of somatic reprogramming, the expression of both genes gradually decreased by day 7 post-doxycycline induction. Meanwhile, an increase in E-cadherin and SSEA1 expression was observed on day 7 post-doxycycline induction, indicating early events of cell fate change. On day 14, the expression of Esrrb, Oct4 and Nanog became apparent and continued to increase until day 21. During the final stage of stabilization, the expression of PECAM and Dppa3 increased abruptly on day 21 and day 14, respectively (Fig. 7C) . The time course expression profiling during iPSC generation demonstrated that the somatic reprogramming of MEF Col1a1 4F2A-Oct4-GFP is consistent with previous observations using viral vector-mediated transgene transduction approaches and takes a similar if not identical route.
To further verify whether the iPSCs are pluripotent and can generate three germ layers, the iPSCs were injected into the flanks of NOD-SCID mice. After 3 weeks the teratomas were harvested, and histological analysis was performed to detect the generation of the three germ layers. As shown in Fig. 8D , typical cell types corresponding to the three germ layers were present in the iPSC-derived teratomas demonstrating the pluripotency of iPSCs. Finally, to verify whether the iPSCs derived from MEF Col1a1 4F2A-Oct4-GFP can contribute to different tissues in vivo, chimeric mice were generated by transferring the iPSCs into E3.5 blastocysts. Eighty-four blastocysts were injected, and 3 out of 14 pups were chimeras. As shown in Fig. 8A , the chimeric pups were generated with 75%, 25% and 20% chimeric ratio from right to left, respectively. To verify the potential germline transmission, the quantitative analysis of germ cell related genes was performed. In Fig. 8B , the expression of Dppa3, Prdm14, Ddx4 and Prdm1 was comparable to the JM8A3 and R1 ESCs. Finally, the genotype of offspring bred from the chimeric mice demonstrated the capability of iPSC Col1a1 4F2A-Oct4-GFP in germline transmission as shown in Fig. 8C .
Discussion
Unraveling the mechanisms of somatic reprogramming will allow us to understand how cell fate can be changed by overcoming epigenetic barriers set up during differentiation and facilitate the production of autologous cells or tissues for future clinical applications. Conventionally, viral vector-mediated introduction of Yamanaka factors into candidate cells has been employed to efficiently drive the process of somatic reprogramming under certain culture conditions and resulted in a~0.01-0.5% efficiency of iPSC generation [1, 4, [7] [8] [9] . However, the uneven transduction of each factor into cells results in heterogeneous populations with unsynchronized behaviors, hampering further molecular interrogations. In this study, we adopted a Col1a1 4F2A-Oct4-GFP mouse strain with a defined location of transgene insertion as well as a regulated copy number. Although the Col1a1 4F2A-Oct4-GFP mouse possesses several unprecedented advantages that can enable its use as a disease model for drug screening, it displays inefficiency in iPSC generation (0.005%) due to insufficient driving force for somatic reprogramming from only two copies each of the Yamanaka factors. Here, we report that by optimizing culture conditions, we were able to overcome the previously encountered difficulties and achieved up to approximately 8% iPSC generation rate from MEF Col1a1 4F2A-Oct4-GFP . Previous studies have shown that the use of different strategies for somatic reprogramming, including various transgene contexts and different medium composition, cause fibroblasts to take different routes to acquire pluripotency [16, 18, [25] [26] [27] . In this study, we tested various chemically defined media coupled with the conventional Yamanaka factors knocked-in at the Col1a1 locus to examine the process of somatic reprogramming. In line with previous reports, cell proliferation and kinetics of somatic reprogramming were variable in the different media; the cell fate of fibroblasts is altered in the presence of Yamanaka factors, but this does not ensure the achievement of a state of pluripotency. Since the unique epigenetic pattern established in each specialized cell during development is considered the first-encountered barrier for cell fate conversion or pluripotency re-acquisition, cell proliferation is thus a prerequisite to erase epigenetic memories and is considered an indispensable process for changing the identity of a cell [14, 15] . However, our present study showed that although several media promoted MEF Col1a1 4F2A-Oct4-GFP proliferation to a large extent, they were unable to facilitate iPSC generation. This observation is consistent with the previous report [28] .
The reason for the failure of MEF Col1a1 4F2A-Oct4-GFP to acquire pluripotency in several media that promoted fibroblast proliferation could be multifactorial. For examples, the inability to generate iPSCs in the presence of Yamanaka factors and with VC6TFN medium could have resulted from conflicting routes taken during the progression of reprogramming, since the genetic path toward the generation of iPSCs by the VC6TFN medium is different from that of conventional Yamanaka factors [27] . Additionally, the level of expression of exogenous OSKM in MEF Col1a1 4F2A-Oct4-GFP is critical for iPSC generation. With only two copies of Yamanaka factors in each cell, rapidly proliferating MEF Col1a1 4F2A-Oct4-GFP may not be able cross the epigenetic barrier due to the lack of effective concentration of each factor (Fig. 4B) . Moreover, inability to generate iPSCs could be due to contact inhibition resulting from rapid cell proliferation. Since the density of MEF Col1a1 4F2A-Oct4-GFP in a six-well plate at confluence is approximately 3 9 10 5 cells/well, most of the tested media caused MEF Col1a1 4F2A-Oct4-GFP to reach confluency by day 2. Thus, further cell division was halted due to contact inhibition and this stopped epigenetic remodeling as well. When 10-fold fewer MEF Col1a1 4F2A-Oct4-GFP (1 9 10 4 ) were seeded, the same iPSC generation rate resulted as that observed earlier (with 1 9 10 5 MEF Col1a1 4F2A-Oct4-GFP seeded) with both cMEF ICR and cSNL feeders and iCD medium (Fig. 5A) . Therefore, an adequate seeding density at the onset of iPSC generation is one of the critical criteria for avoiding contact inhibition during somatic reprogramming [27] . However, if the process of somatic reprogramming has passed through the MET, contact inhibition will no longer be the issue in halting the progression of reprogramming since those cells can pile up to form each individual clone as long as the culture system can still support cell growth.
MET has been recognized as a major route for fibroblasts to acquire pluripotency at the onset of somatic reprogramming, and it is mainly mediated by the TGF-b signal transduction pathway [6, 29] . Removing or inactivating TGF-b from the serum has been demonstrated to improve iPSC generation [29] . To evaluate the role of TGF-b in our system, SB431542 (a TGF-b inhibitor) was used. Interestingly, our results showed that SB431542 neither affected MEF Col1a1 4F2A-Oct4-GFP proliferation nor promoted iPSC generation in any of the serum-containing media. Hence, we concluded that the amount of TGF-b in the serum that we used may not have had a significant role in the somatic reprogramming of MEF Col1a1 4F2A-Oct4-GFP . However, the effect of SB431542 was observed on the chosen feeders, since a five-fold differential iPSC production rate was observed between cMEF ICR and cSNL in the iCD medium. Our data showed that cMEF ICR produced more TGF-b than cSNL. In the presence of 10 lM SB431542, the cMEF ICR feeders could achieve the rate of iPSC generation seen with the cSNL feeder cells (~8%; Fig. 6B ).
All the iPSC clones generated in this study expressed the core pluripotency-associated network genes, although variability was observed among JM8A mESC, R1 mESC and iPSC Col1a1 4F2A-Oct4-GFP . These variations may have resulted from the different genetic backgrounds. Teratoma formation, chimeric mouse production assays and germline transmission indicated that the iPSCs derived from MEF Col1a1 4F2A-Oct4-GFP are bona fide pluripotent cells, including the iPSCs generated with either iCD or iSF medium. In this study, we used iCD medium leading to the generation of iPSCs at an 8% efficiency. The use of different media resulted in the expression of Oct4-GFP at different time points post-doxycycline induction. However, earlier detection of Oct4-GFP expression did not correlate with fast kinetics of somatic reprogramming. For example, the earliest detection of Oct4-GFP was on the second day of induction in the iSF medium. However, most of the Oct4-GFP-positive cells were arrested as single cells, thereby failing to form colonies under these conditions. If at all, the true iPSC clones arose around day 7 post-induction in all tested media. Thus, we were unable to distinguish the differences in kinetics between media in the context of MEF Col1a1 4F2A-Oct4-GFP . Although the original study that used iCD medium resulted in approx. 10% iPSC generation efficiency, the higher copy number of transgenes as well as the different transgene context in the different genetic background may account for such variability [16] . Also, previous reports adopting a similar transgenic system with a different genetic background achieved > 80% reprogramming rate [28, [30] [31] [32] [33] [34] . In addition to the variation of genetic background, the major difference was in the medium adopted. In the current study, we used the chemically defined iCD medium without serum. Including serum in iCD medium reduces the efficiency of somatic reprogramming in our case. This could be due to components in the serum directing the path of reprogramming apart from and/or in conflict with the iCD.
Currently, the somatic reprogramming of MEF Col1a1 4F2A-Oct4-GFP required feeder cells to support pluripotency acquisition. In line with the fact that different feeder cells result in differential iPSC production, the microenvironment plays an important role in somatic reprogramming. In conclusion, MEF Col1a1 4F2A-Oct4-GFP can be a valuable tool for mechanistic studies of somatic reprogramming as well as for application in small molecular drug-screening by circumventing the problem of heterogeneity.
Materials and methods
Mouse husbandry and genotyping
To breed the triple-transgenic mice, three independent transgenic lines were obtained from The Jackson Laboratory (Bar Harbor, ME, USA), with stock numbers 006965, 008214 and 011004. All breeding procedures and animal manipulations were strictly performed according to the guidelines of Laboratory Animal Center, CGU. The PCRbased genotyping was performed following the protocols of The Jackson Laboratory.
Cell culture
MEFs were derived from E13.5 mouse embryos and cultured in MEF medium (high glucose DMEM, 10% FBS, 10 mM HEPES, 0.1 mM nonessential amino acid, 100 U penicillin and streptomycin and 2 mM L-glutamine). For the preparation of mitotically inactive MEFs, MEFs were passaged twice and exposed to gamma radiation at a dose of 4000 cGy. The mitotically inactivate MEFs were used as feeder cells for iPSC generation. The recipes of the different culture media, including iSF, iCD and VC6TFN, are given in the original papers [12, 16, 17] .
For proliferation assays, 5 9 10 4 cells were seeded in each well of a six-well plate coated with 0.1% gelatin. The next day, the medium was changed to different culture media. The cells were harvested and counted on 2, 4 and 6 days after being seeded. ) were seeded into each well of a six-well plate atop a gamma-irradiated feeder layer that was seeded 1 day earlier. The next day, the culture medium was changed to each of the corresponding testing media containing 1.5 lgÁmL À1 doxycycline.
Quantitative RT-PCR
Medium was renewed daily. Fluorescence microscopy was used to observe iPSC generation starting from the seventh day after doxycycline induction.
Immunostaining Cells (8 9 10 4 ) were seeded in one well of a chamber slide (Thermo Fisher Scientific, cat. no. 138121) coated with a 1 : 10 diluted Matrigel. The next day, the cells were fixed with 4% paraformaldehyde for 20 min, followed by rinsing with 19 PBS containing 0.1% Triton X-100 and 3% donkey serum for 5 min. To perform blocking, PBS containing 0.05% Tween-20, 3% donkey serum and 1 mM NaN 3 was used and incubated at 4°C overnight. For immunostaining, the primary antibody was diluted with the blocking solution at a 1 : 200 ratio. Primary antibodies against the following targets were used: Nanog (Abcam, Cambridge, MA, USA, cat. no. ab80892), Oct3/4 (Santa Cruz Biotechnology, Dallas, TX, USA, cat. no. sc-5279), SSEA1 (Millipore, Billerica, MA, USA, cat. no. MAB4301) and Sox2 (Abcam, cat. no. ab59776). The fixed cells were incubated with the respective primary antibody for 2 h at room temperature. Following three rinses, secondary antibodies including Dylight TM 594-conjugated AffiniPure donkey anti-mouse IgG (H+L) (Jackson ImmunoResearch Laboratories, West Grove, PA, USA, cat. no. 715-515-150) and Alexa Fluor Ò 594-conjugated AffiniPure donkey anti-rabbit IgG (H+L) (Jackson ImmunoResearch, cat. no. 711-585-152) were diluted at 1 : 500, applied to the samples and incubated for 1 h at room temperature. DAPI-containing mounting medium (Invitrogen, cat. no. P36935) was applied to the samples for labeling nuclei right before microscopic examination.
ELISA and soft agar assay for quantitation of functional LIF
To quantify the amount of LIF secretion from the cSNL feeder, the cSNL feeders were cultured in the MEF medium for 24 h and then the culture medium was collected for the ELISA assay (MLF00, R&D Systems, Minneapolis, MN, USA) according to the manufacturer's instruction.
To determine if functional LIF existed in the cSNL conditioned medium, a soft agar assay was performed on the M1 cell (TIB-192, ATCC, Manassas, VA, USA). Briefly, the bottom agar was made of 0.5% agarose/medium (RPMI 1640 w/10% FBS and penicillin and streptomycin) in a 35 mm culture dish. After solidifying, the 0.35% agarose mixed with 5 9 10 3 M1 cells was poured on top of it. To determine the M1 cell proliferation promotion by LIF, 1 mL of the cSNL conditioned medium or iCD + LIF was added on top and cultured in a 37°C incubator. The M1 colonies were visualized and counted by 0.005% Crystal Violet stain after 72 h.
TGF-b releasing assay
MEFs Col1a1 4F2A-Oct4-GFP were seeded onto one well of a six-well plate with MEF medium. Next day, the cultured MEF medium were replaced by the 1.5 lgÁmL À1 doxycycline containing iCD medium. A time course experiment was conducted for detecting the releasing TGF-b from different feeders by collecting the conditioned medium at 6, 12 and 24 h post-iCD medium culturing. A TGF-b ELISA kit (Arigo, Burlington, NC, USA, cat. no. ARG80211) was used. The detection procedure followed the manufacturer's instructions.
Teratoma formation and chimeric mouse generation iPSCs (2 9 10 6 ) were mixed with Matrigel (BD Biosciences, San Jose, CA, USA, cat. no. 354234) and injected into the flanks of 6-to 8-week-old NOD-SCID mice. Teratomas were harvested at~2-3 weeks post-injection and fixed in 4% formaldehyde (Capitol Scientific, Austin, TX, USA, cat. no. H121-08). The sectioned tissues were stained with hematoxylin and eosin for histological examination to verify the presence of three germ layers. For the production of chimeric mice, the iPSCs derived from MEF Col1a1 4F2A-Oct4-GFP were cultured in R1 ESC medium with 1 lM PD0325901, 2 lM SU5402 and 3 lM CHIR99021 on the cMEF ICR feeder layer. Following 84 blastocyst injections and embryo transfer, three of the 14 pups were found to be chimeras with 75%, 25% and 20% chimeric ratios.
